Biotech

All Articles

Former Seagen chief executive officer introduces new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) expert Seagen was actually sold to Pfizer in 2013 for an immens...

Ironwood makes more bid for $1B GI drug with brand new subgroup data

.On the heels of a period 3 succeed that stopped working to make an impression on entrepreneurs, Iro...

Novartis inks $150M offer for autoimmune molecular glue

.Don't cease Monte Rosa Rehabs currently. The Boston-based biotech is enjoying after signing a manag...

Jade takes officer staff along with Chinook vets-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of significant management hirings, firings a...

Septerna goes social with upsized offering of $288M

.Celebrating his business's upsized initial public offering (IPO), Septerna chief executive officer ...

AbbVie makes Richter wealthier, paying out $25M to create breakthrough deal

.AbbVie has actually come back to the source of its antipsychotic goliath Vraylar seeking another sm...

GenSight gets in ultimate full weeks of money path as income flow slips by of grasp

.GenSight Biologics is full weeks off of losing funds. Once again. The biotech just possesses enough...

AZ licenses thrown away uncommon ailment medicine to Monopar Therapies

.Monopar Rehabs is recouping a medicine from the scrap heap of AstraZeneca's unusual ailment pipe. I...

Arcus' brand-new HIF-2a information in renal cancer mean possible advantage over Merck's Welireg, professionals say

.Along with brand-new information out on Arcus Biosciences' experimental HIF-2a prevention, one grou...

Roche bets as much as $1B to grow Dyno gene therapy distribution treaty

.After forming a genetics therapy collaboration with Dyno Rehabs in 2020, Roche is back for addition...